sábado, 12 de mayo de 2018

Brca AND (genetic OR genomic) AND review - PubMed - NCBI

Brca AND (genetic OR genomic) AND review - PubMed - NCBI

BRCA

From PubMed

PubMed comprises more than 27 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.






Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology.
Stecklein SR, Jensen RA.
Transl Res. 2012 Sep;160(3):178-97. doi: 10.1016/j.trsl.2012.01.022. Epub 2012 Feb 9. Review.

PMID:
 
22683426
Similar articles
2.
Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK.
J Clin Oncol. 2008 Sep 10;26(26):4282-8. doi: 10.1200/JCO.2008.16.6231.

PMID:
 
18779615
Similar articles
3.
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R.
Ann Intern Med. 2014 Feb 18;160(4):255-66. Review.

PMID:
 
24366442
Similar articles
4.
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.
Pruthi S, Gostout BS, Lindor NM.
Mayo Clin Proc. 2010 Dec;85(12):1111-20. doi: 10.4065/mcp.2010.0414. Review.

PMID:
 
21123638
 
Free PMC Article
Similar articles
5.
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
Valachis A, Nearchou AD, Lind P.
Breast Cancer Res Treat. 2014 Apr;144(3):443-55. doi: 10.1007/s10549-014-2890-1. Epub 2014 Feb 25. Review.

PMID:
 
24567198
Similar articles
6.
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation [Internet].
Nelson HD, Fu R, Goddard K, Mitchell JP, Okinaka-Hu L, Pappas M, Zakher B.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Dec.

PMID:
 
24432435
 
Free Books & Documents
Similar articles
7.
PARP inhibitors in BRCA gene-mutated ovarian cancer and beyond.
Banerjee S, Kaye S.
Curr Oncol Rep. 2011 Dec;13(6):442-9. doi: 10.1007/s11912-011-0193-9. Review.

PMID:
 
21913063
Similar articles
8.
Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review.
Finch A, Narod SA.
Maturitas. 2011 Nov;70(3):261-5. doi: 10.1016/j.maturitas.2011.08.001. Epub 2011 Sep 4. Review.

PMID:
 
21893388
Similar articles
9.
Decisions and ethical issues among BRCA carriers and the use of preimplantation geneticdiagnosis.
Quinn GP, Vadaparampil ST, Bower B, Friedman S, Keefe DL.
Minerva Med. 2009 Oct;100(5):371-83. Review.

PMID:
 
19910890
Similar articles
10.
[BRCA 1 and BRCA 2 gens in breast cancer].
Habibović S, Hrgović Z.
Lijec Vjesn. 1998 Oct-Nov;120(10-11):342-8. Review. Croatian.

PMID:
 
19658353
Similar articles
11.
BRCA and beyond: a genome-first approach to familial breast cancer risk assessment.
Trainer AH, Thompson E, James PA.
Discov Med. 2011 Nov;12(66):433-43. Review.

PMID:
 
22127114
 
Free Article
Similar articles
12.
BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.
Finch A, Evans G, Narod SA.
Womens Health (Lond). 2012 Sep;8(5):543-55. doi: 10.2217/whe.12.41.

PMID:
 
22934728
Similar articles
13.
BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.
Laraqui A, Uhrhammer N, Rhaffouli HE, Sekhsokh Y, Lahlou-Amine I, Bajjou T, Hilali F, El Baghdadi J, Al Bouzidi A, Bakri Y, Amzazi S, Bignon YJ.
Dis Markers. 2015;2015:194293. doi: 10.1155/2015/194293. Epub 2015 Feb 28. Review.

PMID:
 
25814778
 
Free PMC Article
Similar articles
14.
Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.
Baretta Z, Mocellin S, Goldin E, Olopade OI, Huo D.
Medicine (Baltimore). 2016 Oct;95(40):e4975. Review.

PMID:
 
27749552
 
Free PMC Article
Similar articles
15.
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.
Hyman DM, Zhou Q, Iasonos A, Grisham RN, Arnold AG, Phillips MF, Bhatia J, Levine DA, Aghajanian C, Offit K, Barakat RR, Spriggs DR, Kauff ND.
Cancer. 2012 Aug 1;118(15):3703-9. doi: 10.1002/cncr.26655. Epub 2011 Dec 2.

PMID:
 
22139894
 
Free PMC Article
Similar articles
16.
Review of risk factors for the development of contralateral breast cancer.
Lizarraga IM, Sugg SL, Weigel RJ, Scott-Conner CE.
Am J Surg. 2013 Nov;206(5):704-8. doi: 10.1016/j.amjsurg.2013.08.002. Epub 2013 Sep 6. Review.

PMID:
 
24016706
Similar articles
17.
BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.
Nicoletto MO, Donach M, De Nicolo A, Artioli G, Banna G, Monfardini S.
Cancer Treat Rev. 2001 Oct;27(5):295-304. Review.

PMID:
 
11871866
Similar articles
18.
[Detection and occurrence of BRCA 1 gene mutation in patients with carcinoma of the breast and ovary].
Jancárková N, Zikán M, Pohlreich P, Freitag P, Matous B, Zivný J.
Ceska Gynekol. 2003 Jan;68(1):11-6. Czech.

PMID:
 
12708108
Similar articles
19.
[Review of the literature on BRCA 1 and BRCA 2].
Saponara R, Menditto A, Russo G, Musone R, Balbi GC, Balbi C.
Minerva Ginecol. 2001 Feb;53(1 Suppl 1):72-4. Review. Italian. No abstract available.

PMID:
 
11526726
Similar articles
20.
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.
U.S. Preventive Services Task Force.
Ann Intern Med. 2005 Sep 6;143(5):355-61. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547.

PMID:
 
16144894
Similar articles
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)